Skip to content

The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man

The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00789451
Enrollment
12
Registered
2008-11-11
Start date
2008-08-31
Completion date
2010-10-31
Last updated
2010-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischaemic Heart Diseases

Keywords

Ischaemia reperfusion, t-PA, Fibrinolysis, Endothelial function

Brief summary

Heart attacks are usually caused by a blood clot blocking an artery supplying blood to the heart. Current treatments are designed at relieving this blockage as quickly as possible to minimise damage to the heart muscle. However in restoring the supply of blood local damage known as ischaemia-reperfusion injury may occur. The aim of this study is to assess how clot forming and clot dissolving pathways are affected during this process, and examine the role of a natural inflammatory hormone, bradykinin. This will help us to understand the mechanism by which ischaemia-reperfusion injury may occur and to devise new treatments for heart attacks.

Interventions

Forearm blood flow measured by venous occlusion plethysmography during interarterial infusion of substance P (2,4,8 pmol/min). Venous blood sampling via cannula in antecubital fossa.

Sponsors

University of Aarhus
CollaboratorOTHER
University of Oxford
CollaboratorOTHER
University of Edinburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males between 18-65 years of ages, non-smokers.

Exclusion criteria

* Any concurrent illness or chronic medical condition. Concurrent use of vasoactive medication. Smoking history.

Design outcomes

Primary

MeasureTime frame
Net t-PA release from the endothelium after ischaemia reperfusionThroughout the study

Secondary

MeasureTime frame
Change in forearm blood flow after ischaemia reperfusionthroughout the study
Change in platelet-monocyte-binding after ischaemia reperfusionThroughout the study

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026